[시장보고서]재조합 단백질 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

재조합 단백질 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Recombinant Proteins Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

상품코드 : 1773777

리서치사 : Persistence Market Research

발행일 : 2025년 07월

페이지 정보 : 영문 195 Pages

라이선스 & 가격 (부가세 별도)

US $ 4,995

￦ 7,282,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295

￦ 10,636,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495

￦ 12,385,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.

한글목차

샘플 요청 목록에 추가

Persistence Market Research는 이번에 세계의 재조합 단백질 시장에 관한 종합 보고서를 발표했습니다. 시장 성장 촉진요인·동향·기회·과제 등의 중요한 시장 역학을 철저하게 평가하고, 시장 구조에 관한 상세 인사이트를 제공하고 있습니다. 이 조사 리포트는 2025-2032년 세계 재조합 단백질 시장의 예측 성장 궤도를 설명하는 독점 데이터와 통계를 게재하고 있습니다.

주요 인사이트

재조합 단백질 시장 규모(2025년) : 16억 520만 달러
예측 시장 금액(2032년) : 28억 1,320만 달러
세계 시장 성장률(CAGR 2025-2032년) : 8.3%

재조합 단백질 시장 - 리포트 범위 :

재조합 단백질은 다양한 치료, 진단 및 연구 분야에서 중요한 역할을 하고 있습니다. 유전공학 기술로 생산된 이들 단백질은 질병을 표적 치료하고, 백신 개발을 지원하며, 생명공학 및 분자생물학 분야의 첨단 연구를 촉진합니다. 재조합 단백질 시장은 제약 및 생명공학 산업, 학술 및 연구 기관, 진단 실험실, 연구 및 제조 위탁 기관에 공급되고 있습니다. 시장 성장의 원동력은 생물제제에 대한 수요 증가, 맞춤형 의료에서의 용도 확대, 단백질 발현 시스템의 기술적 진보로 인한 재조합 단백질의 수율, 순도, 기능성의 향상입니다.

시장 성장 촉진요인:

세계 재조합 단백질 시장은 만성질환 및 감염성 질환 증가, 생물학적 치료 및 진단 툴에 대한 수요 증가 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 생명공학 연구개발에 대한 투자 증가와 유전자 편집 및 세포배양 기술의 발전으로 재조합 단백질 생산의 효율성과 확장성이 크게 향상되고 있습니다. 또한 COVID-19 팬데믹 기간 중 두드러진 백신 개발에서 재조합 단백질의 채택이 증가하면서 현대 치료법에서 재조합 단백질의 중요한 역할을 강조하고 있습니다. 재생의학, 종양학, 면역치료 분야에서 재조합 단백질의 사용 범위가 확대되면서 제약회사들이 미충족 의료 수요를 충족시키기 위해 새로운 생물제제를 찾고 있으며, 시장 성장을 더욱 촉진하고 있습니다.

시장 성장 억제요인:

재조합 단백질 시장은 유망한 성장 잠재력을 가지고 있지만, 높은 생산 비용, 복잡한 제조 공정, 생물제제에 적용되는 엄격한 규제 요건과 관련된 문제에 직면해 있습니다. 재조합 단백질 개발에는 많은 시간과 투자가 필요하므로 신규 시장 진출기업이나 소규모 생명공학 기업에게는 장벽이 될 수 있습니다. 또한 재조합 단백질의 면역원성, 안정성, 확장성 등의 문제는 제품의 효능과 안전성에 영향을 미칠 수 있으며, 엄격한 품질관리와 검증 프로토콜이 필요합니다. 또한 특정 지역, 특히 비용에 민감한 신흥 시장에서의 생물제제의 가격 압박과 상환의 불확실성 또한 시장 침투를 가로막는 장애물이 되고 있습니다. 이러한 장애물을 극복하기 위해서는 기술 혁신, 전략적 제휴, 재조합 단백질 기반 솔루션에 대한 폭넓은 접근을 보장하기 위한 규제 경로의 간소화가 필요합니다.

시장 기회:

재조합 단백질 시장은 정밀의료, 첨단 치료제, 생명공학 연구로의 적용 확대로 인해 큰 성장 기회를 제공합니다. 안정성, 효능이 향상되고 면역원성이 감소된 차세대 재조합 단백질의 개발은 암, 자가면역질환과 같은 복잡한 질병에 대한 치료적 개입에 새로운 길을 열어줄 것입니다. 합성생물학, CRISPR 기반 유전자 편집, 식물 기반 및 무세포 플랫폼과 같은 새로운 발현 시스템과 같은 새로운 기술은 생산 비용을 낮추고 확장성을 향상시킬 수 있는 혁신적인 접근법을 제공합니다. 또한 바이오시밀러, 진단 및 백신 플랫폼 개발에서 재조합 단백질에 대한 수요가 증가함에 따라 시장 개발자들에게 유리한 기회를 제공합니다. 전략적 파트너십, R&D 투자, 비용 효율적인 재조합 단백질 솔루션의 경쟁 환경은 진화하는 시장 상황을 파악하고 경쟁 우위를 유지하는 데 매우 중요합니다.

이 보고서에서 다룬 주요 질문

전 세계 재조합 단백질 시장의 성장을 가속하는 주요 요인은?
제약, 진단, 연구 분야에서 채택이 진행되고 있는 재조합 단백질의 유형과 용도는?
기술의 발전은 재조합 단백질 시장 경쟁 구도를 어떻게 변화시키고 있는가?
재조합 단백질 시장에 기여하고 있는 주요 기업은 어디이며, 시장 관련성을 유지하기 위해 어떤 전략을 채택하고 있는가?
세계 재조합 단백질 시장에서의 새로운 동향과 전망은?

주요 하이라이트
- 시장 예측
- 시장 규모와 전년대비 성장률
- 절대적 매출 기회
시장 규모 분석과 예측
- 과거 시장 규모 분석(2019-2024년)
- 현재 시장 규모 분석·예측(2025-2032년)
세계의 재조합 단백질 시장 전망 : 제품 유형
- 서론/주요 조사 결과
- 과거 시장 규모 분석 : 제품 유형별(2019-2024년)
- 현재 시장 규모 분석·예측 : 제품 유형별(2025-2032년)
  - 호르몬
  - 사이토카인과 성장인자
  - 면역 체크포인트 단백질
  - 대사 효소
  - 항체
  - 조절 단백질
  - 구조 단백질
  - 콜라겐
  - 기타
- 시장의 매력 분석 : 제품 유형
세계의 재조합 단백질 시장 전망 : 재조합 단백질 발현 시스템
- 서론/주요 조사 결과
- 과거 시장 규모 분석 : 재조합 단백질 발현 시스템별(2019-2024년)
- 현재 시장 규모 분석·예측 : 재조합 단백질 발현 시스템별(2025-2032년)
  - 포유류 발현 시스템
  - 세균 발현 시스템
  - 효모 발현 시스템
  - 곤충 세포 발현 시스템
  - 기타
- 시장의 매력 분석 : 재조합 단백질 발현 시스템
세계의 재조합 단백질 시장 전망 : 용도
- 서론/주요 조사 결과
- 과거 시장 규모 분석 : 용도별(2019-2024년)
- 현재 시장 규모 분석·예측 : 용도별(2025-2032년)
  - 생물의학 연구
  - 진단과 치료
  - Drug Discovery와 의약품 개발
  - 식품 용도
  - 화장품 용도
  - 기타
시장의 매력 분석 : 용도
세계의 재조합 단백질 시장 전망 : 최종사용자
- 서론/주요 조사 결과
- 과거 시장 규모 분석 : 최종사용자별(2019-2024년)
- 현재 시장 규모 분석·예측 : 최종사용자별(2025-2032년)
  - 바이오의약품 기업
  - 계약 연구기관
  - 학술연구기관
  - 진단 검사실
  - 식품 업계
  - 화장품 업계
  - 기타
시장의 매력 분석 : 최종사용자

제6장 세계의 재조합 단백질 시장 전망 : 지역

주요 하이라이트
과거 시장 규모 분석 : 지역별(2019-2024년)
현재·향후 시장 규모 분석·예측 : 지역별(2025-2032년)
- 북미
- 유럽
- 동아시아
- 남아시아·오세아니아
- 라틴아메리카
- 중동 및 아프리카
시장의 매력 분석 : 지역

제7장 북미의 재조합 단백질 시장 전망

제8장 유럽의 재조합 단백질 시장 전망

제9장 동아시아의 재조합 단백질 시장 전망

제10장 남아시아·오세아니아의 재조합 단백질 시장 전망

제11장 라틴아메리카의 재조합 단백질 시장 전망

제12장 중동 및 아프리카의 재조합 단백질 시장 전망

제13장 경쟁 구도

시장 점유율 분석, 2025년
시장 구조
- 경쟁 격화 맵 : 시장별
- 경쟁 대시보드
기업 개요(상세 : 개요, 재무, 전략, 최근 개발)
- Thermo Fisher Scientific, Inc.
- Merck KGaA
- Sino Biological
- GenScript
- Bio-Rad Laboratories, Inc
- STEMCELL Technologies
- FUJIFILM Irvine Scientific
- Rockland Immunochemical
- ACROBiosystems
- Miltenyi Biotec
- Bio-Techne
- Proteintech Group, Inc.
- Enzo Biochem Inc.
- RayBiotech, Inc.
- BioLegend, Inc.
- Abcam Limited
- SYNBIO Technologies
- BPS Bioscience, Inc.
- Revvity
- Creative BioMart
- G-Biosciences(Geno Technology Inc.)
- Bioxcell
- Corning Incorporated
- Biosensis Pty Ltd.

제14장 부록

조사 방법
조사의 전제조건
두자어와 약어

KSA

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the worldwide market for recombinant proteins. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global recombinant proteins market from 2025 to 2032.

Key Insights:

Recombinant Proteins Market Size (2025E): USD 1,605.2 Million
Projected Market Value (2032F): USD 2,813.2 Million
Global Market Growth Rate (CAGR 2025 to 2032): 8.3%

Recombinant Proteins Market - Report Scope:

Recombinant proteins play a crucial role across various therapeutic, diagnostic, and research applications. Produced through genetic engineering techniques, these proteins enable targeted treatments for diseases, support vaccine development, and facilitate advanced research in biotechnology and molecular biology. The recombinant proteins market caters to the pharmaceutical and biotechnology industries, academic and research institutions, diagnostic laboratories, and contract research and manufacturing organizations. Market growth is driven by increasing demand for biologics, expanding applications in personalized medicine, and technological advancements in protein expression systems, leading to higher yields, purity, and functionality of recombinant proteins.

Market Growth Drivers:

The global recombinant proteins market is propelled by several key factors, including rising prevalence of chronic and infectious diseases, fueling demand for biologic therapies and diagnostic tools. Growing investments in biotechnology research and development, coupled with advancements in gene editing and cell culture technologies, have significantly enhanced the efficiency and scalability of recombinant protein production. Additionally, the increasing adoption of recombinant proteins in vaccine development, notably evident during the COVID-19 pandemic, has underscored their critical role in modern therapeutics. The expanding scope of recombinant proteins in regenerative medicine, oncology, and immunotherapy further stimulates market growth, as pharmaceutical companies seek novel biologics to address unmet medical needs.

Market Restraints:

Despite promising growth prospects, the recombinant proteins market faces challenges related to high production costs, complex manufacturing processes, and stringent regulatory requirements governing biologics. The development of recombinant proteins often entails significant time and investment, posing barriers for new market entrants and smaller biotech firms. Furthermore, issues such as immunogenicity, stability, and scalability of recombinant proteins can affect product efficacy and safety, requiring rigorous quality control and validation protocols. Pricing pressures and reimbursement uncertainties for biologics in certain regions, particularly in cost-sensitive emerging markets, also pose challenges to widespread market penetration. Overcoming these hurdles necessitates innovation, strategic collaborations, and streamlined regulatory pathways to ensure broader access to recombinant protein-based solutions.

Market Opportunities:

The recombinant proteins market presents significant growth opportunities driven by expanding applications in precision medicine, advanced therapeutics, and biotechnology research. The development of next-generation recombinant proteins with enhanced stability, efficacy, and reduced immunogenicity opens new avenues for therapeutic interventions in complex diseases such as cancer and autoimmune disorders. Emerging technologies, including synthetic biology, CRISPR-based gene editing, and novel expression systems like plant-based or cell-free platforms, offer innovative approaches to lower production costs and improve scalability. Additionally, growing demand for recombinant proteins in the development of biosimilars, diagnostics, and novel vaccine platforms creates lucrative opportunities for market players. Strategic partnerships, investments in R&D, and the commercialization of cost-effective recombinant protein solutions will be pivotal in capturing the evolving market landscape and sustaining competitive advantage.

Key Questions Answered in the Report:

What are the primary factors driving the growth of the recombinant proteins market globally?
Which recombinant protein types and applications are driving adoption across pharmaceutical, diagnostic, and research sectors?
How are technological advancements reshaping the competitive landscape of the recombinant proteins market?
Who are the key players contributing to the recombinant proteins market, and what strategies are they employing to maintain market relevance?
What are the emerging trends and future prospects in the global recombinant proteins market?

Competitive Intelligence and Business Strategy:

These companies invest significantly in research and development to produce high-quality recombinant proteins for therapeutics, diagnostics, and research applications. Collaborations with pharmaceutical companies, academic institutions, and contract manufacturing organizations facilitate technology transfer, accelerate product development, and enhance market reach. Additionally, emphasis on improving manufacturing efficiency, ensuring regulatory compliance, and expanding product portfolios helps market leaders address diverse customer needs and maintain competitiveness in the rapidly evolving biotechnology landscape.

Key Companies Profiled:

Thermo Fisher Scientific, Inc.
Merck KGaA
Sino Biological
GenScript
Bio-Rad Laboratories, Inc
STEMCELL Technologies
FUJIFILM Irvine Scientific
Rockland Immunochemical
ACROBiosystems
Miltenyi Biotec
Bio-Techne
Proteintech Group, Inc.
Enzo Biochem Inc.
RayBiotech, Inc.
BioLegend, Inc.
Abcam Limited
SYNBIO Technologies
BPS Bioscience, Inc.
Revvity
Creative BioMart
G-Biosciences (Geno Technology Inc.)
Bioxcell
Corning Incorporated
Biosensis Pty Ltd.
Others

Recombinant Proteins Market Research Segmentation:

The recombinant proteins market encompasses a diverse range of products, applications, and end-user segments, addressing various therapeutic, diagnostic, and research needs.

By Product Type:

Hormones
Cytokines and Growth Factors
Immune Checkpoint Proteins
Metabolic Enzymes
Antibodies
Regulatory Proteins
Structural Proteins
Collagen
Others

By Recombinant Protein Expression Systems:

Mammalian Expression Systems
Bacterial Expression Systems
Yeast Expression Systems
Insect Cells Expression Systems
Others

By Application:

Biomedical Research
Diagnostics and Therapeutics
Drug Discovery and Development
Food Application
Cosmetic Application
Others

By End User:

Biopharma Companies
Contract Research Organizations
Academic Research Institutes
Diagnostic Laboratories
Food Industry
Cosmetic Industry
Others

By Region:

North America
Europe
East Asia
South Asia and Oceania
Latin America
Middle East and Africa

1. Executive Summary

1.1. Global Recombinant Proteins Market Snapshot, 2025 and 2032
1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Macro-Economic Factors
- 2.3.1. Global Sectorial Outlook
- 2.3.2. Global GDP Growth Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Advantages and Disadvantages of Current Therapeutic Protein Expression Systems
3.4. List of Key Suppliers of Recombinant Proteins, By Region
3.5. Key Promotional Strategies by Manufacturers
3.6. Value Chain Analysis
3.7. PESTLE Analysis
3.8. Porter's Five Force Analysis

4. Price Trend Analysis, 2019-2032

4.1. Key Highlights
4.2. Key Factors Impacting Product Prices
4.3. Pricing Analysis, By Product Type
4.4. Regional Prices and Product Preferences

5. Global Recombinant Proteins Market Outlook:

5.1. Key Highlights
- 5.1.1. Market Projections
- 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
- 5.1.3. Absolute $ Opportunity
5.2. Market Size (US$ Mn) Analysis and Forecast
- 5.2.1. Historical Market Size (US$ Mn) Analysis, 2019-2024
- 5.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2025-2032
5.3. Global Recombinant Proteins Market Outlook: Product Type
- 5.3.1. Introduction / Key Findings
- 5.3.2. Historical Market Size (US$ Mn) and Analysis, By Product Type, 2019-2024
- 5.3.3. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
  - 5.3.3.1. Hormones
  - 5.3.3.2. Cytokines and Growth Factors
  - 5.3.3.3. Immune Checkpoint Proteins
  - 5.3.3.4. Metabolic Enzymes
  - 5.3.3.5. Antibodies
  - 5.3.3.6. Regulatory Proteins
  - 5.3.3.7. Structural Proteins
  - 5.3.3.8. Collagen
  - 5.3.3.9. Others
- 5.3.4. Market Attractiveness Analysis: Product Type
5.4. Global Recombinant Proteins Market Outlook: Recombinant Protein Expression Systems
- 5.4.1. Introduction / Key Findings
- 5.4.2. Historical Market Size (US$ Mn) and Analysis, By Recombinant Protein Expression Systems, 2019-2024
- 5.4.3. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
  - 5.4.3.1. Mammalian Expression Systems
  - 5.4.3.2. Bacterial Expression Systems
  - 5.4.3.3. Yeast Expression Systems
  - 5.4.3.4. Insect Cells Expression Systems
  - 5.4.3.5. Others
- 5.4.4. Market Attractiveness Analysis: Product Type
5.5. Global Recombinant Proteins Market Outlook: Application
- 5.5.1. Introduction / Key Findings
- 5.5.2. Historical Market Size (US$ Mn) Analysis, By Application, 2019-2024
- 5.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
  - 5.5.3.1. Biomedical Research
  - 5.5.3.2. Diagnostics and Therapeutics
  - 5.5.3.3. Drug Discovery and Development
  - 5.5.3.4. Food Application
  - 5.5.3.5. Cosmetic Application
  - 5.5.3.6. Others
5.6. Market Attractiveness Analysis: Application
5.7. Global Recombinant Proteins Market Outlook: End User
- 5.7.1. Introduction / Key Findings
- 5.7.2. Historical Market Size (US$ Mn) Analysis, By End User, 2019-2024
- 5.7.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
  - 5.7.3.1. Biopharma Companies
  - 5.7.3.2. Contract Research Organizations
  - 5.7.3.3. Academic Research Institutes
  - 5.7.3.4. Diagnostic Laboratories
  - 5.7.3.5. Food Industry
  - 5.7.3.6. Cosmetic Industry
  - 5.7.3.7. Others
5.8. Market Attractiveness Analysis: End User

6. Global Recombinant Proteins Market Outlook: Region

6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) and Analysis, By Region, 2019-2024
6.3. Current Market Size (US$ Mn) and Analysis and Forecast, By Region, 2025-2032
- 6.3.1. North America
- 6.3.2. Europe
- 6.3.3. East Asia
- 6.3.4. South Asia and Oceania
- 6.3.5. Latin America
- 6.3.6. Middle East & Africa
6.4. Market Attractiveness Analysis: Region

7. North America Recombinant Proteins Market Outlook:

7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
- 7.2.1. By Country
- 7.2.2. By Product Type
- 7.2.3. By Recombinant Protein Expression Systems
- 7.2.4. By Application
- 7.2.5. By End User
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 7.3.1. U.S.
- 7.3.2. Canada
7.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
- 7.4.1. Hormones
- 7.4.2. Cytokines and Growth Factors
- 7.4.3. Immune Checkpoint Proteins
- 7.4.4. Metabolic Enzymes
- 7.4.5. Antibodies
- 7.4.6. Regulatory Proteins
- 7.4.7. Structural Proteins
- 7.4.8. Collagen
- 7.4.9. Others
7.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
- 7.5.1. Mammalian Expression Systems
- 7.5.2. Bacterial Expression Systems
- 7.5.3. Yeast Expression Systems
- 7.5.4. Insect Cells Expression Systems
- 7.5.5. Others
7.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 7.6.1. Biomedical Research
- 7.6.2. Diagnostics and Therapeutics
- 7.6.3. Drug Discovery and Development
- 7.6.4. Food Application
- 7.6.5. Cosmetic Application
- 7.6.6. Others
7.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 7.7.1. Biopharma Companies
- 7.7.2. Contract Research Organizations
- 7.7.3. Academic Research Institutes
- 7.7.4. Diagnostic Laboratories
- 7.7.5. Food Industry
- 7.7.6. Cosmetic Industry
- 7.7.7. Others
7.8. Market Attractiveness Analysis

8. Europe Recombinant Proteins Market Outlook:

8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
- 8.2.1. By Country
- 8.2.2. By Product Type
- 8.2.3. By Recombinant Protein Expression Systems
- 8.2.4. By Application
- 8.2.5. By End User
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 8.3.1. Germany
- 8.3.2. France
- 8.3.3. U.K.
- 8.3.4. Italy
- 8.3.5. Spain
- 8.3.6. Russia
- 8.3.7. Turkey
- 8.3.8. Rest of Europe
8.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
- 8.4.1. Hormones
- 8.4.2. Cytokines and Growth Factors
- 8.4.3. Immune Checkpoint Proteins
- 8.4.4. Metabolic Enzymes
- 8.4.5. Antibodies
- 8.4.6. Regulatory Proteins
- 8.4.7. Structural Proteins
- 8.4.8. Collagen
- 8.4.9. Others
8.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
- 8.5.1. Mammalian Expression Systems
- 8.5.2. Bacterial Expression Systems
- 8.5.3. Yeast Expression Systems
- 8.5.4. Insect Cells Expression Systems
- 8.5.5. Others
8.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 8.6.1. Biomedical Research
- 8.6.2. Diagnostics and Therapeutics
- 8.6.3. Drug Discovery and Development
- 8.6.4. Food Application
- 8.6.5. Cosmetic Application
- 8.6.6. Others
8.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 8.7.1. Biopharma Companies
- 8.7.2. Contract Research Organizations
- 8.7.3. Academic Research Institutes
- 8.7.4. Diagnostic Laboratories
- 8.7.5. Food Industry
- 8.7.6. Cosmetic Industry
- 8.7.7. Others
8.8. Market Attractiveness Analysis

9. East Asia Recombinant Proteins Market Outlook:

9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
- 9.2.1. By Country
- 9.2.2. By Product Type
- 9.2.3. By Recombinant Protein Expression Systems
- 9.2.4. By Application
- 9.2.5. By End User
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 9.3.1. China
- 9.3.2. Japan
- 9.3.3. South Korea
9.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
- 9.4.1. Hormones
- 9.4.2. Cytokines and Growth Factors
- 9.4.3. Immune Checkpoint Proteins
- 9.4.4. Metabolic Enzymes
- 9.4.5. Antibodies
- 9.4.6. Regulatory Proteins
- 9.4.7. Structural Proteins
- 9.4.8. Collagen
- 9.4.9. Others
9.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
- 9.5.1. Mammalian Expression Systems
- 9.5.2. Bacterial Expression Systems
- 9.5.3. Yeast Expression Systems
- 9.5.4. Insect Cells Expression Systems
- 9.5.5. Others
9.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 9.6.1. Biomedical Research
- 9.6.2. Diagnostics and Therapeutics
- 9.6.3. Drug Discovery and Development
- 9.6.4. Food Application
- 9.6.5. Cosmetic Application
- 9.6.6. Others
9.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 9.7.1. Biopharma Companies
- 9.7.2. Contract Research Organizations
- 9.7.3. Academic Research Institutes
- 9.7.4. Diagnostic Laboratories
- 9.7.5. Food Industry
- 9.7.6. Cosmetic Industry
- 9.7.7. Others
9.8. Market Attractiveness Analysis

10. South Asia & Oceania Recombinant Proteins Market Outlook:

10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
- 10.2.1. By Country
- 10.2.2. By Product Type
- 10.2.3. By Recombinant Protein Expression Systems
- 10.2.4. By Application
- 10.2.5. By End User
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 10.3.1. India
- 10.3.2. Southeast Asia
- 10.3.3. ANZ
- 10.3.4. Rest of South Asia & Oceania
10.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
- 10.4.1. Hormones
- 10.4.2. Cytokines and Growth Factors
- 10.4.3. Immune Checkpoint Proteins
- 10.4.4. Metabolic Enzymes
- 10.4.5. Antibodies
- 10.4.6. Regulatory Proteins
- 10.4.7. Structural Proteins
- 10.4.8. Collagen
- 10.4.9. Others
10.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
- 10.5.1. Mammalian Expression Systems
- 10.5.2. Bacterial Expression Systems
- 10.5.3. Yeast Expression Systems
- 10.5.4. Insect Cells Expression Systems
- 10.5.5. Others
10.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 10.6.1. Biomedical Research
- 10.6.2. Diagnostics and Therapeutics
- 10.6.3. Drug Discovery and Development
- 10.6.4. Food Application
- 10.6.5. Cosmetic Application
- 10.6.6. Others
10.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 10.7.1. Biopharma Companies
- 10.7.2. Contract Research Organizations
- 10.7.3. Academic Research Institutes
- 10.7.4. Diagnostic Laboratories
- 10.7.5. Food Industry
- 10.7.6. Cosmetic Industry
- 10.7.7. Others
10.8. Market Attractiveness Analysis

11. Latin America Recombinant Proteins Market Outlook:

11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
- 11.2.1. By Country
- 11.2.2. By Product Type
- 11.2.3. By Recombinant Protein Expression Systems
- 11.2.4. By Application
- 11.2.5. By End User
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 11.3.1. Brazil
- 11.3.2. Mexico
- 11.3.3. Rest of Latin America
11.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
- 11.4.1. Hormones
- 11.4.2. Cytokines and Growth Factors
- 11.4.3. Immune Checkpoint Proteins
- 11.4.4. Metabolic Enzymes
- 11.4.5. Antibodies
- 11.4.6. Regulatory Proteins
- 11.4.7. Structural Proteins
- 11.4.8. Collagen
- 11.4.9. Others
11.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
- 11.5.1. Mammalian Expression Systems
- 11.5.2. Bacterial Expression Systems
- 11.5.3. Yeast Expression Systems
- 11.5.4. Insect Cells Expression Systems
- 11.5.5. Others
11.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 11.6.1. Biomedical Research
- 11.6.2. Diagnostics and Therapeutics
- 11.6.3. Drug Discovery and Development
- 11.6.4. Food Application
- 11.6.5. Cosmetic Application
- 11.6.6. Others
11.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 11.7.1. Biopharma Companies
- 11.7.2. Contract Research Organizations
- 11.7.3. Academic Research Institutes
- 11.7.4. Diagnostic Laboratories
- 11.7.5. Food Industry
- 11.7.6. Cosmetic Industry
- 11.7.7. Others
11.8. Market Attractiveness Analysis

12. Middle East & Africa Recombinant Proteins Market Outlook:

12.1. Key Highlights
12.2. Historical Market Size (US$ Mn) and Analysis, By Market, 2019-2024
- 12.2.1. By Country
- 12.2.2. By Product Type
- 12.2.3. By Recombinant Protein Expression Systems
- 12.2.4. By Application
- 12.2.5. By End User
12.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
- 12.3.1. GCC Countries
- 12.3.2. Egypt
- 12.3.3. South Africa
- 12.3.4. Northern Africa
- 12.3.5. Rest of Middle East & Africa
12.4. Current Market Size (US$ Mn) and Analysis and Forecast, By Product Type, 2025-2032
- 12.4.1. Hormones
- 12.4.2. Cytokines and Growth Factors
- 12.4.3. Immune Checkpoint Proteins
- 12.4.4. Metabolic Enzymes
- 12.4.5. Antibodies
- 12.4.6. Regulatory Proteins
- 12.4.7. Structural Proteins
- 12.4.8. Collagen
- 12.4.9. Others
12.5. Current Market Size (US$ Mn) and Analysis and Forecast, By Recombinant Protein Expression Systems, 2025-2032
- 12.5.1. Mammalian Expression Systems
- 12.5.2. Bacterial Expression Systems
- 12.5.3. Yeast Expression Systems
- 12.5.4. Insect Cells Expression Systems
- 12.5.5. Others
12.6. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
- 12.6.1. Biomedical Research
- 12.6.2. Diagnostics and Therapeutics
- 12.6.3. Drug Discovery and Development
- 12.6.4. Food Application
- 12.6.5. Cosmetic Application
- 12.6.6. Others
12.7. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
- 12.7.1. Biopharma Companies
- 12.7.2. Contract Research Organizations
- 12.7.3. Academic Research Institutes
- 12.7.4. Diagnostic Laboratories
- 12.7.5. Food Industry
- 12.7.6. Cosmetic Industry
- 12.7.7. Others
12.8. Market Attractiveness Analysis

13. Competition Landscape

13.1. Market Share Analysis, 2025
13.2. Market Structure
- 13.2.1. Competition Intensity Mapping By Market
- 13.2.2. Competition Dashboard
13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 13.3.1. Thermo Fisher Scientific, Inc.
  - 13.3.1.1. Overview
  - 13.3.1.2. Segments and Product Types
  - 13.3.1.3. Key Financials
  - 13.3.1.4. Market Developments
  - 13.3.1.5. Market Strategy
- 13.3.2. Merck KGaA
- 13.3.3. Sino Biological
- 13.3.4. GenScript
- 13.3.5. Bio-Rad Laboratories, Inc
- 13.3.6. STEMCELL Technologies
- 13.3.7. FUJIFILM Irvine Scientific
- 13.3.8. Rockland Immunochemical
- 13.3.9. ACROBiosystems
- 13.3.10. Miltenyi Biotec
- 13.3.11. Bio-Techne
- 13.3.12. Proteintech Group, Inc.
- 13.3.13. Enzo Biochem Inc.
- 13.3.14. RayBiotech, Inc.
- 13.3.15. BioLegend, Inc.
- 13.3.16. Abcam Limited
- 13.3.17. SYNBIO Technologies
- 13.3.18. BPS Bioscience, Inc.
- 13.3.19. Revvity
- 13.3.20. Creative BioMart
- 13.3.21. G-Biosciences (Geno Technology Inc.)
- 13.3.22. Bioxcell
- 13.3.23. Corning Incorporated
- 13.3.24. Biosensis Pty Ltd.

14. Appendix

14.1. Research Methodology
14.2. Research Assumptions
14.3. Acronyms and Abbreviations